XII Medical develops a patient-centric neuromodulation therapy to improve treatment and quality of life for people with obstructive sleep apnea. The company is clinical-stage and its platform is currently limited to investigational use and not available for sale. Led by CEO Garrett Schwab and founded in 2017, XII Medical is based in Union City, California. The company intends to use new funding to further product and clinical development. XII raised $45M in a recently announced financing to support those efforts. XII Medical is a private health technology company focused on treating obstructive sleep apnea (OSA). It is led by President and CEO Garrett Schwab and is based in Union City, California. The company is developing a proprietary, patient-centric solution for people suffering from OSA. XII Medical plans to use new funding to advance the development of that solution. The article does not disclose revenue, users, or other operating metrics. The company previously counted Cleveland Clinic as a founding investor.

Total raised

$75M

Funding rounds

2

Latest round

Series B

Latest activity

Aug 2024